MedTrace Logo

Diabetes Type One in Pregnancy and Continuos Glucose Monitoring

NCT04997460 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-08-09

No results posted yet for this study

Summary

Type I diabetes mellitus (T1DM) affects about 0.1-0.2% of all pregnancies. T1DM in pregnancy increases the risk of maternal and neonatal complications.

Continuous glucose monitoring systems (CGM) provide a continuous display of measured glucose. Studies have shown improved pregnancy outcomes for patients with T1DM using CGM when compared to capillary blood glucose measurements.

This prospective observational study analyses impact of glycemic variability on development of large-for-gestational-age neonates and effects of hypoglycemia during pregnancy on pregnancy outcomes.

Furthermore, overall glycemic regulation, different insulin metrics and C-peptide concentration during pregnancy will also be assesed.

Conditions

  • Large-for-gestational-age Neonates
  • Glycemic Variability
  • Hypoglycemia
  • Pregnancy Outcomes
  • C-peptide

Sponsors & Collaborators

  • Clinical Hospital Centre Zagreb

    lead OTHER

Principal Investigators

  • Maja Baretic · Clinical Hospital Centre Zagreb

  • Marina Ivanisevic · Clinical Hospital Centre Zagreb

  • Gloria Leksic · Clinical Hospital Centre Zagreb

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-11
Primary Completion
2024-01-11
Completion
2024-01-11

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04997460 on ClinicalTrials.gov